COVID-19 Vaccine Market is expected to Hit US$ 29.98 billion by 2033 | Emerging Companies - Inovio Pharmaceuticals, Moderna, BioNTech, Medicago, Afrigen

DataM Intelligence has unveiled its latest report on the "COVID-19 Vaccine Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing COVID-19 Vaccine Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/covid-19-vaccine-market?sz

The Global COVID-19 Vaccine Market size reached US$ 13.43 billion in 2024 and is expected to reach US$ 29.98 billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.

The COVID-19 Vaccine Market refers to the global industry focused on the research, development, manufacturing, distribution, and commercialization of vaccines designed to prevent infection from the SARS-CoV-2 virus. It includes mRNA, viral vector, protein subunit, and inactivated vaccines supplied by pharmaceutical companies, governments, and international organizations. The market is driven by ongoing immunization programs, booster dose demand, emerging variants, and public health initiatives aimed at controlling and mitigating the spread of COVID-19 worldwide.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/covid-19-vaccine-market?sz

Recent Industry Developments: United States

✅ March 2026: Pfizer and BioNTech halted a large U.S. clinical trial for their updated COVID-19 vaccine (targeting adults aged 50-64) due to low participant enrollment, reflecting declining vaccine demand and stricter regulatory requirements.

✅ February 2026: The U.S. Centers for Disease Control and Prevention (CDC) canceled/postponed its Advisory Committee on Immunization Practices (ACIP) meeting, delaying key decisions on COVID-19 vaccine recommendations amid broader policy restructuring and reduced federal focus on mRNA vaccine funding.

✅ January-February 2026: U.S. health authorities intensified genomic surveillance of emerging SARS-CoV-2 variants (e.g., BA.3.2) to guide future vaccine updates and strain selection for upcoming immunization cycles.

Recent Industry Developments: Japan

✅ March-April 2026: Pharmaceutical and biotech companies in Japan continued steady investment in vaccine R&D infrastructure and next-generation technologies, supporting long-term COVID-19 vaccine adaptation and broader biologics pipelines.

✅ February 2026: Japan's regulatory authorities emphasized platform-based vaccine development frameworks (mRNA, viral vector, protein-based), enabling faster approvals and lifecycle management of COVID-19 vaccines and future pandemic preparedness.

✅ January 2026: Next-generation COVID-19 vaccines, including self-amplifying mRNA platforms (e.g., Kostaive / ARCT-154), gained further international momentum with approvals expanding beyond Japan (e.g., UK authorization in January 2026), strengthening Japan's role in advanced vaccine innovation.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/covid-19-vaccine-market?sz

List of the Key Players in the COVID-19 Vaccine Market:

Pfizer/BioNTech
Moderna, Inc.
AstraZeneca.
Johnson & Johnson (Janssen Scientific Affairs, LLC)
SINOVAC
CanSino Biologics Inc.
Novavax.
Sanofi/GSK
Beijing Institute of Biological Products Co., Ltd.
Serum Institute of India Pvt. Ltd.
Gamaleya Research Institute

How Does Market Research Work in the COVID-19 Vaccine Market?

Market research for the COVID-19 Vaccine Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of COVID-19 Vaccine Market:

✅ February 2026: Sanofi completed acquisition of Dynavax Technologies
➠ Sanofi finalized its takeover of Dynavax, a U.S.-based vaccine company known for its CpG 1018 adjuvant, widely used in COVID-19 and next-generation vaccines.
➠ The deal strengthens Sanofi's vaccine portfolio and enhances its adjuvant technology capabilities for infectious diseases.

✅ January 2026: Ongoing consolidation impact from Sanofi-Dynavax deal (closing phase)
➠ Although announced in late 2025, the transaction moved into its final closing phase in early 2026, marking one of the most significant vaccine-focused acquisitions influencing COVID-19 vaccine technology platforms in 2026.

✅ January 2026: AstraZeneca acquisition of Modella AI (strategic vaccine R&D support)
➠ AstraZeneca acquired Modella AI to strengthen its data-driven vaccine and drug development capabilities, indirectly supporting COVID-19 and infectious disease vaccine innovation through advanced AI-powered clinical research and biomarker discovery.

Segments Covered in the COVID-19 Vaccine Market 2026:

By Infection Type: SARS-CoV-2, HCoVs, Others.

By Vaccine Type: mRNA Vaccines, Viral Vector Vaccines, Inactivated Virus Vaccines, Protein Subunit Vaccines, Live Attenuated Vaccines, Others.

By Route of Administration: Intramuscular, Subcutaneous, Oral.

By Age Group: Below 18 Years, Above 18 Years.

By End-User: Hospitals, Specialty Clinics, Others.

Regional Analysis of the COVID-19 Vaccine Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=covid-19-vaccine-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the COVID-19 Vaccine Market in 2025?
◆ What is the projected growth rate of the COVID-19 Vaccine Market through 2033?
◆ Who are the key players in the COVID-19 Vaccine Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website:https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.